Uwe Berner

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

CONSORT statement: extension to cluster randomised trials

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review

The unit of analysis error in studies about physicians’ patient care behavior

Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease

Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation

Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma

Cost-Effectiveness of Using Recombinant Human Thyroid-Stimulating Hormone before Radioiodine Ablation for Thyroid Cancer: The Canadian Perspective

Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy

Consort 2010 statement: extension to cluster randomised trials

Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy

Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with ¹³¹I Is Associated with Lowered Radiotoxicity

Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

Recombinant Human Thyrotropin-Assisted Radioiodine Therapy for Patients with Metastatic Thyroid Cancer Who Could Not Elevate Endogenous Thyrotropin or Be Withdrawn from Thyroxine

Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce

Radioiodine Treatment of Metastatic Thyroid Cancer: Relative Efficacy and Side Effect Profile of Preparation by Thyroid Hormone Withdrawal Versus Recombinant Human Thyrotropin

Clinical photodynamic therapy of head and neck cancers—A review of applications and outcomes

Revised Response Criteria for Malignant Lymphoma

Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer

Photodynamic Therapy in Dentistry

Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix

Guidelines for the management of thyroid cancer

Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology

Role of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma

18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.

Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.

Iodine Biokinetics and Radioiodine Exposure after Recombinant Human Thyrotropin-Assisted Remnant Ablation in Comparison with Thyroid Hormone Withdrawal

Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?

Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline

Positron Emission Tomography in Patients with Hodgkin's Disease: Correlation to Histopathologic Subtypes

Monitoring the Efficacy of Iodine‐131‐MIBG Therapy using Fluorine‐18‐FDG‐PET

Positron Emission Tomography for the Staging of Hodgkin's Lymphoma - Increasing the Body of Evidence in Favor of the Method

Sentinel Node Biopsy as Staging Tool in a Multimodality Treatment Approach to Cancer of the Oral Cavity and the Oropharynx

rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I.

Physician compliance in the management of hypertensive patients.